Tempus AI (NASDAQ:TEM) delivered a very mixed Q4 2024 earnings report that saw its shares sell off about 15% after hours. The main takeaway here is that Tempus' core business is expected to grow ...

JPMorgan downgraded Tempus AI (TEM) to Neutral from Overweight with a price target of $55, up from $50. The company reported Q4 results in-line with the preannouncement and its 2025 guidance ...

Google Agreement: Extended for another five years. Tempus AI Inc (NASDAQ:TEM) reported a 35.8% year-over-year revenue growth in Q4 2024, with gross profit growth accelerating to 49.7%. The company ...

Please go ahead. Thank you, Jason. Good afternoon and welcome to Tempus' Fourth Quarter 2024 Conference Call. This afternoon Tempus released results for the quarter and year ended December 31 ...

Tempus is expected to releases its 2024 fiscal-year fourth-quarter earnings report after the market closes. Analysts estimate a loss per share of 20 cents and revenue of $203.12 million. Get 5 ...

Hanna Porter hit a walk-off grand slam to lift Newbury Park to a 7-4 win over Chaminade in a season opener. Nikki Kennedy went 1 for 2 with a double and an RBI, Yasmin Topinko was 1 for 3 with an ...

Tempus AI has raised an additional $300 million in incremental debt financing from alternative investment manager Ares Management that is intended to support the firm's recent acquisition of Ambry ...

Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to enhance patient care. Undoubtedly, AI has transformed many industries ...

The financing is intended to support Tempus’ previously announced acquisition of Ambry Genetics ("Ambry"), which closed on February 3, 2025. Combined with $260 million of capital provided in ...

Her son Scott Goldberg is accused in her death. The 22-year-old from Newbury Park also faces charges in the attack of his father. A Newbury Park man pleaded not guilty Monday to the alleged murder ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other health information services stocks. Health Information Services stocks have become a key ...

Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation. The goal of the collaboration is to advance targeted therapy development for follicular lymphoma by ...